Target selection lead discovery medicinal drug discovery strategy design 5 powerpoint presentation templates.

•

0 likes•171 views

The document outlines the multi-step drug discovery process, including cellular and genetic target identification, compound synthesis and isolation, library development, drug affinity and selectivity testing, animal disease modeling, and clinical trials. Key steps involve genomics, proteomics, high-throughput screening, medicinal chemistry, in vitro and in vivo studies to identify lead candidates and refine drug properties before progressing to clinical testing.

Business Technology

All images are 100% editable in Powerpoint
“Change color, size and orientation of any icon to your liking”

www.slideteam.net

Ungrouping the object

2
1

3

1. Right click the object.
2. Choose Group and then Ungroup.
3. Click beside the object and drag the arrow over it.

www.slideteam.net

Edit Color

2 3
1

1. Select the shape to change the color and Right click the object( click any object which you
want to change color)
2. Choose Format Shape in the dialog box.
3. Choose “Fill” in the Format Shape box then “Solid” or “Gradient” depending on the
appearance of the object. Change colour as shown in the picture.
www.slideteam.net

The document outlines the key stages of the drug discovery process, including identifying genetic and cellular targets, synthesizing and isolating compounds through combinatorial chemistry and high-throughput screening, developing structure-activity relationships through in silico and in vitro studies, evaluating drug affinity and selectivity in cellular and disease models, testing lead candidates in animal models of disease states, and conducting clinical trials and therapeutics in humans.

Target selection lead discovery medicinal drug discovery process design 5 pow...

SlideTeam.net

Drug discovery process style 5 powerpoint presentation slides db ppt templates

SlideTeam.net

The document outlines the key stages in the drug discovery process, including target selection, lead discovery, drug development, preclinical testing, and clinical trials. Genetic and cellular targets are identified through genomics and proteomics. Combinatorial chemistry and high-throughput screening are used to develop compound libraries and identify potential drug candidates. Lead compounds are refined through medicinal chemistry and testing in cellular and animal disease models. Top candidates then progress to clinical trials in humans to test for safety and efficacy.

Traditional drug discovery process design 6 powerpoint ppt slides.

SlideTeam.net

The document describes two approaches to drug discovery: the traditional approach and the SWITCH drug re-profiling approach. The traditional approach involves lengthy timelines of 0.5-6 years across target identification, validation, lead identification, candidate optimization, pre-clinical trials, and clinical trials. The SWITCH approach aims to shorten timelines by mining existing drug data to identify new therapeutic uses for existing drugs and performing a clinical proof of concept trial within 0.5-1 year on a re-profiled drug.

Drug discovery process style 6 powerpoint presentation templates

SlideTeam.net

The document describes two approaches to drug discovery: traditional drug discovery and a SWITCH drug re-profiling approach. The traditional approach involves multiple sequential steps over 6-10 years, including target identification, validation, lead identification, candidate optimization, pre-clinical testing, and clinical trials. The SWITCH approach uses data mining to identify existing drugs that could be re-purposed for new indications, potentially shortening the process to just 0.5-1 years for target identification and proof-of-concept clinical trials on re-profiled drugs.

Drug discovery process style 5 powerpoint presentation templates

SlideTeam.net

The document describes the key stages in the drug discovery process, including cellular and genetic target identification, compound synthesis and isolation, high-throughput screening, lead optimization, preclinical testing in animal models and in vitro/in vivo studies, and clinical trials in humans. The flow diagram shows the iterative process moving from early research to identify biological targets through compound development and testing, culminating in clinical evaluation and potential approval of new therapeutics.

How to make create genomic research target molecules drug discovery strategy ...

SlideTeam.net

The document outlines the key steps in the drug discovery process: 1. Identification of target molecules through genomic research and functional analysis of genes and enzymes. 2. Discovery of seed lead compounds through high-throughput screening and combinatorial chemistry. 3. Scrutiny of drug candidates including estimation of drug efficacy and safety evaluation. 4. Manufacturing development and clinical studies prior to new drug application and launch.

How to make create genomic research target molecules drug discovery strategy ...

SlideTeam.net

The document describes the Institute for Cell Dynamics and Biotechnology, which conducts research in systems biology using a multidisciplinary approach. The key goals of the Institute are to conduct frontier research in cell function and dynamics using systems biology models, and to apply this research to important scientific and societal problems. It supports over 70 young researchers and postdocs and has an extensive international collaborations network. The research focuses on areas like metabolic networks, protein engineering, and metabolomics.

Representing Microarray Experiment Metadata Using Provenance Models

Jim McCusker

This document discusses representing experimental metadata as provenance using provenance models. It argues that experimental metadata is a type of provenance and evaluates mapping microarray metadata onto the Open Provenance Model and Proof Markup Language. It describes converting microarray data from MAGE-TAB format to RDF and then applying rules to generate equivalent provenance representations. Both OPM and PML are found to adequately represent the data, though some attributes are missing from each. Future work could integrate this provenance data with other systems and evaluate coverage on additional use cases.

Biotechnology as Career Option 2012

Reportbioinformatics

Molecular and data visualization in drug discovery

Deepak Bandyopadhyay

Bioinformatica t9-t10-biocheminformatics

Prof. Wim Van Criekinge

The document provides information about a bioinformatics lesson and exam. It states that there will be no lesson on December 4th. It then discusses the structure of the bioinformatics exam, which will randomly select images from a set of 713 images to display on a web page using JavaScript. The remainder of the document discusses various topics in comparative genomics, drug discovery, and other areas of bioinformatics.

The Aquapower Management System

macgoilladubh

The document introduces the Aquapower Management System (AMS), which is structured into three sections and based on written procedures and documentation to ensure quality products and services. The AMS meets ISO 9001 requirements. Key responsibilities include the Quality Coordinator overseeing AMS implementation and the Managing Director ensuring adequate resources. Planning and processes cover purchasing, monitoring, customer communications and continual improvement.

Determinants of health ss1 (1)

mi282an1

This document discusses heredity and how it is transmitted from ancestors to descendants through genes. It provides examples of how certain genetic conditions like cystic fibrosis and fragile X syndrome are inherited. It also discusses how environmental factors like pollution and housing conditions can impact health. Further, it examines how other determinants such as culture, media, and technology can influence health through things like food advertising, social norms, and increased screen time.

Arm connectedPantech Solutions Pvt Ltd

Presentation1nicolegurke3

Tik 1salsabilajihans

Membuat tabel pada dokumendwibawa

Bpi training details

Aaron Husak

The document outlines the eligibility requirements and schedule for Building Performance Institute (BPI) training, which includes being 18+, unemployed/underemployed, having legal work documents, testing at a 10th grade reading and math level or higher, and being a Home Energy Rating System (HERS) rater. Participants must attend an orientation, complete a reading and math assessment with potential remediation, and take a required 24-hour Title 24 training. The tentative BPI training schedule is in October, November, and January, with tuition, exams, and parking at $0 cost.

Christmas 2009

cinejohnson

Sophia spends time with her father and Ken enjoying leftovers in the kitchen on Christmas 2009 in Cave Creek. Several photos show Sophia feeding her father corn, wearing monkey mittens and hat, eating donuts with her father and Ken, and exploring her mother's closet while walking in high heels. The mother notes Sophia's frequent eating and includes a photo of the family resting to shame her husband and Ken for iPhone use.

El Gran Milagro

Barego

Este documento contiene varias frases clave de un ángel de la guarda dirigidas a personas que enfrentan dolor y dificultades. El ángel les aconseja escuchar a Dios a través de la oración y la Palabra, y ofrecerle no solo sus propias necesidades sino también las de los demás. También les recuerda que aunque a veces no se vea, el amor de Dios está presente a través de personas, eventos y situaciones, y se hace especialmente presente en la Eucaristía.

Bondia.cat 24/12/2013

Bondia Lleida Sl

InnovateED

mzb269

This document describes an application called InnovateED that aims to help teachers and administrators identify disabilities within student populations and issues like over-identification. It will compare a district's data to peer districts, analyze relationships between disabilities and performance, and help with resource allocation. Tables show special education enrollment and spending data over time for Moline school district compared to state averages and peer districts. Moline spends less than peers but achieves median results. A chart shows that some districts that spend more per special education student score above the median on achievement tests, while others that spend less still achieve above the median.

DON DRAPER, AVATARES E TWITTERTAINMENT: O COMPORTAMENTO DOS FÃS NA ERA TRANSM...

Sheron Neves

Meu artigo publicado na Revista Comunicação e Cultura (Universidade Católica Portuguesa de Lisboa, no. 12, 2011, pp. 117-135). O artigo propõe examinar o comportamento dos fãs de TV no atual ambiente transmidiático, usando como referência o personagem Don Draper da série norte-americana Mad Men e sua transformação em celebridade. A ideia é examinar o impacto das cultura da convergência sobre as comunidades de fãs e sobre as estratégias de marketing das empresas produtoras de conteúdo. Os fãs são hoje convidados a imergir em universos imaginários, fazendo com que as fronteiras entre realidade e ficção se confundam; torna-se assim essencial entender este novo perfil de fã, que dialoga com personagens fictícios no Twitter, se reinventa em avatares e é obcecado com sua própria imagem nas redes sociais.

Real Scan

Philipperoche

Real-Scan provides high-fidelity 3D models directly from 2D medical scans that can be manipulated in real-time on low-cost hardware anywhere. It was founded in 2010 in Seattle by Sylvain Ordureau to make 3D patient scans affordable and accessible to medical students, educators, and practitioners. Real-Scan works with Nvidia and universities to develop new visualization techniques and leverage advances in GPU processing to deliver supercomputer-level performance at low cost.

Narendra2305

PLAY AND GAME, NEW MEDIA

hannejacobs

What's hot

Synthetic Biology and Data-Driven Synthetic Biology for Personalized Medicine...

RussellHanson

20120615_Granatum_COST_v2

Christos Kannas

ICDB

Rosemarie Tapia

Representing Microarray Experiment Metadata Using Provenance Models

Jim McCusker

Biotechnology as Career Option 2012

Reportbioinformatics

Molecular and data visualization in drug discovery

Deepak Bandyopadhyay

Bioinformatica t9-t10-biocheminformatics

Prof. Wim Van Criekinge

What's hot (7)

Synthetic Biology and Data-Driven Synthetic Biology for Personalized Medicine...

20120615_Granatum_COST_v2

ICDB

Representing Microarray Experiment Metadata Using Provenance Models

Biotechnology as Career Option 2012

Molecular and data visualization in drug discovery

Bioinformatica t9-t10-biocheminformatics

Viewers also liked

The Aquapower Management System

macgoilladubh

Determinants of health ss1 (1)

mi282an1

Arm connectedPantech Solutions Pvt Ltd

Presentation1nicolegurke3

Tik 1salsabilajihans

Membuat tabel pada dokumendwibawa

Bpi training details

Aaron Husak

Christmas 2009

cinejohnson

El Gran Milagro

Barego

Bondia.cat 24/12/2013

Bondia Lleida Sl

InnovateED

mzb269

DON DRAPER, AVATARES E TWITTERTAINMENT: O COMPORTAMENTO DOS FÃS NA ERA TRANSM...

Sheron Neves

Real Scan

Philipperoche

Narendra2305

PLAY AND GAME, NEW MEDIA

hannejacobs

Vh namerican dream_project2

Joe Scozzaro

The document discusses different perspectives on the American Dream. It begins by stating that the American Dream can mean different things like wealth, family, or love, but ultimately leads to one's own definition of happiness. While the American Dream provides freedom, it can also lead to debt or disappointment. The document then explores various meanings of the American Dream such as equality of opportunity, consumerism, family, wealth through hard work. It also discusses how the American Dream can be both liberating and oppressive. Overall, the document presents a nuanced view of the complex and multifaceted nature of the American Dream.

Usa today overview

Miami-Dade County Public Schools

The document provides an overview of the Reading with USA TODAY program which includes 56 lessons that use USA TODAY newspaper to teach reading strategies to students, with each lesson incorporating the newspaper, teaching a reading strategy, and allowing students to practice and collaborate. The program is intended to motivate students and improve reading ability through meaningful, high interest content from USA TODAY that covers real-world topics in an engaging style.

Managing Multidimensional Historical

Arul Suju

This document proposes a framework for managing and querying multidimensional historical data distributed across an unstructured peer-to-peer network. When data is published, it is summarized into a synopsis containing an index and sub-synopses storing compressed data portions. The index and sub-synopses are distributed across the network with suitable replication to provide coverage for queries. The framework supports data publication and querying while ensuring peer autonomy and handling volatile peers through prompt reaction to disconnections to prevent broken index references.

2013 GMC Yukon SLE Philadelphia

Fred Beans GMC

Si Nanodotsgiulia2987

Viewers also liked (20)

The Aquapower Management System

Determinants of health ss1 (1)

Arm connected

Presentation1

Tik 1

Membuat tabel pada dokumen

Bpi training details

Christmas 2009

El Gran Milagro

Bondia.cat 24/12/2013

InnovateED

DON DRAPER, AVATARES E TWITTERTAINMENT: O COMPORTAMENTO DOS FÃS NA ERA TRANSM...

Real Scan

PLAY AND GAME, NEW MEDIA

Vh namerican dream_project2

Usa today overview

Managing Multidimensional Historical

2013 GMC Yukon SLE Philadelphia

Si Nanodots

Similar to Target selection lead discovery medicinal drug discovery strategy design 5 powerpoint presentation templates.

Drug discovery process style 3 powerpoint presentation templates

SlideTeam.net

The document summarizes the key steps in the drug discovery process. It involves: 1) Identifying a biological target molecule through genomic research and functional analysis of genes. 2) Discovering seed lead compounds through high-throughput screening and combinatorial chemistry. 3) Scrutinizing drug candidates through estimation of efficacy, safety evaluation, pharmacokinetics studies, and manufacturing development. 4) Conducting clinical studies and applying for a new drug approval.

Metabolomics. Strategic approach for GC amenable compounds

Joeri Vercammen, PhD

Towards Systems Pharmacology

Philip Bourne

This document discusses systems pharmacology and applying a systems-based approach to understanding drug action and effects. It begins by outlining some big questions in pharmacology research, such as predicting drug efficacy and toxicity. It then discusses concepts like polypharmacology, where one drug can have multiple targets, and how drug binding is a dynamic process. The document proposes using multiscale modeling to simulate these complex biological processes. It describes developing computational methods to explore the large conformational and functional spaces involved. Several applications of these approaches are mentioned, such as drug repositioning and designing personalized medicines. Overall, the document advocates applying systems-level modeling and simulations to better understand how drugs work in the body.

Ts111 Biomarker Solutions

gressero

Biovays is a biomarker solutions provider that offers specialized services to support drug development from target discovery through FDA approval. Their services include biomarker selection and assay development, pharmacodynamics testing, toxicity analysis, and various in vitro and ex vivo assays. By providing biomarker analysis and expertise, Biovays aims to streamline drug development, reduce costs, and improve success rates.

Biology Services

GVK Biosciences

Infographic CV MB

Metin Bilgin

Metin Bilgin is an experienced molecular and cellular biologist with over 12 years of postgraduate research experience. He co-developed the first proteome chip and assay protocols for protein array technology. His research has focused on studying cell cycle regulation, cytochrome P450 metabolism, and nuclear hormone receptor regulated drug metabolism through interactive proteomics, protein expression, and recombinant protein purification techniques. He holds a Ph.D. in Molecular and Cellular Biology from Szeged University and has worked in academic research positions in Turkey, Hungary, the UK, and the US.

Infographic CV MB

Metin Bilgin

Metin Bilgin is an experienced molecular and cellular biologist with over 12 years of postgraduate research experience. He co-developed the first proteome chip and assays for protein array technology. His research has focused on studying cell cycle regulation, cytochrome P450 metabolism, and nuclear hormone receptor-regulated drug metabolism. He is skilled in interactive proteomics, protein expression, purification of multi-protein complexes, and developing high-throughput molecular assays. Currently he works as a postdoctoral research associate at the University of Illinois studying regulation of cytochrome P450 activity by nuclear hormone receptor CAR.

Novel network pharmacology methods for drug mechanism of action identificatio...

laserxiong

Drug Design.ppt

AvinashTripathi97

This document provides an overview of the course Pharm 202 on Computer Aided Drug Design. It discusses the principles of drug discovery including modern target identification, lead identification, and data-driven approaches. The drug discovery process is outlined involving natural products, synthetic chemicals, and biologicals as starting points. Computer aided drug design has evolved from early visualization to modern automation and high-throughput approaches leveraging genomics, structural bioinformatics, and databases. The perspectives of targets, computers, and drugs in discovery are presented.

Infographic CV MB Long

Metin Bilgin

Metin Bilgin is a molecular and cellular biologist with over 12 years of postgraduate research experience. He has expertise in proteomics, protein expression, and characterization. Some of his accomplishments include co-developing the first proteome chip and establishing HTP assay protocols for protein array technology. He has studied various topics like cell cycle regulation, cytochrome P450 metabolism, and nuclear hormone receptor regulated drug metabolism. Currently, he is a postdoctoral research associate studying regulation of cytochrome P450 activity by nuclear hormone receptor CAR. He aims to work for a leading life sciences research company focused on discovery and translational medicine.

Mining Plant Pathogen Genomes for Effectors

Leighton Pritchard

Friend AACR 2013-01-16

Sage Base

This document discusses the evolution of systems biology and its various approaches over time, such as genomic and proteomic profiling, molecular interaction networks, disease models, and drug trials. It notes the movement from studying individual components to constructing network models of entire biological systems and pathways. It also addresses challenges like overgeneralizing findings and the need for more collaborative and open research.

Junyu Ma CV*Ph.D*Biotech/Medical device

Junyu Ma

Concept of genomics, proteomics and metabolomics

Muragendraswami Astagimath

Dr. M. N. Astagimath's presentation discusses genomics, proteomics, and metabolomics. The objectives are to understand the concepts and define each term. Genomics is the study of genomes and involves functional, structural, and epigenomics. Proteomics is the large-scale study of proteins and involves expression, interaction, and biomarker analysis. Metabolomics is the study of small molecule metabolites and their profiles can provide unique fingerprints of cellular processes. A variety of methods are used in each field like sequencing and mass spectrometry. The data has applications in medicine such as diagnosis, risk assessment, and bioengineering.

Similar to Target selection lead discovery medicinal drug discovery strategy design 5 powerpoint presentation templates. (14)

Drug discovery process style 3 powerpoint presentation templates

Metabolomics. Strategic approach for GC amenable compounds

Towards Systems Pharmacology

Ts111 Biomarker Solutions

Biology Services

Infographic CV MB

Novel network pharmacology methods for drug mechanism of action identificatio...

Drug Design.ppt

Infographic CV MB Long

Mining Plant Pathogen Genomes for Effectors

Friend AACR 2013-01-16

Junyu Ma CV*Ph.D*Biotech/Medical device

Concept of genomics, proteomics and metabolomics

PM Surya Ghar Muft Bijli Yojana: Online Application, Eligibility, Subsidies &...

Ksquare Energy Pvt. Ltd.

During the budget session of 2024-25, the finance minister, Nirmala Sitharaman, introduced the “solar Rooftop scheme,” also known as “PM Surya Ghar Muft Bijli Yojana.” It is a subsidy offered to those who wish to put up solar panels in their homes using domestic power systems. Additionally, adopting photovoltaic technology at home allows you to lower your monthly electricity expenses. Today in this blog we will talk all about what is the PM Surya Ghar Muft Bijli Yojana. How does it work? Who is eligible for this yojana and all the other things related to this scheme?

DearbornMusic-KatherineJasperFullSailUni

katiejasper96

Kirill Klip GEM Royalty TNR Gold Lithium Presentation

Kirill Klip

AI Transformation Playbook: Thinking AI-First for Your Business

Arijit Dutta

Prescriptive analytics BA4206 Anna University PPT

Freelance

Recently uploaded (20)

Lukas Rycek - GreenChemForCE - project structure.pptx

Kalyan chart 6366249026 India satta Matta Matka 143 jodi fix

Enhancing Adoption of AI in Agri-food: Introduction

Satta Matka Dpboss Kalyan Matka Results Kalyan Chart

High-Quality IPTV Monthly Subscription for $15

Pro Tips for Effortless Contract Management

1Q24_HYUNDAI CAPITAL SERVICES INC. AND SUBSIDIARIES

Registered-Establishment-List-in-Uttarakhand-pdf.pdf

Efficient PHP Development Solutions for Dynamic Web Applications

Discover the Beauty and Functionality of The Expert Remodeling Service

Satta Matka Dpboss Kalyan Matka Results Kalyan Chart

Kirill Klip GEM Royalty TNR Gold Copper Presentation

Best Competitive Marble Pricing in Dubai - ☎ 9928909666

NIMA2024 | De toegevoegde waarde van DEI en ESG in campagnes | Nathalie Lam |...

CULR Spring 2024 Journal.pdf testing for duke

PM Surya Ghar Muft Bijli Yojana: Online Application, Eligibility, Subsidies &...

DearbornMusic-KatherineJasperFullSailUni

Kirill Klip GEM Royalty TNR Gold Lithium Presentation

AI Transformation Playbook: Thinking AI-First for Your Business

Prescriptive analytics BA4206 Anna University PPT

Target selection lead discovery medicinal drug discovery strategy design 5 powerpoint presentation templates.

1. Drug Discovery Process - Style 5 Cellular & Synthesis & Library Drug Affinity Animal Models Clinical Trials Genetic Targets Isolation Development & Selectivity of Disease States & Therapeutics Combinatorial Structure Activity Cellular Behavioural Genomics Disease Models Studies Chemistry Studies Assay In Silico Mechanism Functional Proteomics Development Screening of Action Imaging Bioinformatics High-throughput Chemical Lead Candidate Ex Vivo Screening Synthesis Refinement Studies Target Lead Medicinal In Vitro In Vivo Selection Discovery Chemistry Studies Studies www.slideteam.net Your logo

2. Drug Discovery Process - Style 5 Cellular & Synthesis & Library Drug Affinity Animal Models Clinical Trials Genetic Targets Isolation Development & Selectivity of Disease States & Therapeutics Combinatorial Structure Activity Cellular Behavioural Genomics Disease Models Studies Chemistry Studies Assay In Silico Mechanism Functional Proteomics Development Screening of Action Imaging Bioinformatics High-throughput Chemical Lead Candidate Ex Vivo Screening Synthesis Refinement Studies Target Lead Medicinal In Vitro In Vivo Selection Discovery Chemistry Studies Studies Text Here Text Here Text Here Text Here Text Here Text Here • Your Text • Your Text • Your Text • Your Text • Your Text • Your Text Goes here Goes here Goes here Goes here Goes here Goes here • Download • Download • Download • Download • Download • Download this this this this this this awesome awesome awesome awesome awesome awesome diagram diagram diagram diagram diagram diagram www.slideteam.net Your logo

3. Drug Discovery Process - Style 5 Cellular & Synthesis & Library Drug Affinity Animal Models Clinical Trials Genetic Targets Isolation Development & Selectivity of Disease States & Therapeutics Combinatorial Structure Activity Cellular Behavioural Genomics Disease Models Studies Chemistry Studies Assay In Silico Mechanism Functional Proteomics Development Screening of Action Imaging Bioinformatics High-throughput Chemical Lead Candidate Ex Vivo Screening Synthesis Refinement Studies Target Lead Medicinal In Vitro In Vivo Selection Discovery Chemistry Studies Studies Text Here Text Here Text Here Text Here Text Here Text Here • Your Text • Your Text • Your Text • Your Text • Your Text • Your Text Goes here Goes here Goes here Goes here Goes here Goes here • Download • Download • Download • Download • Download • Download this this this this this this awesome awesome awesome awesome awesome awesome diagram diagram diagram diagram diagram diagram www.slideteam.net Your logo

4. Drug Discovery Process - Style 5 Cellular & Synthesis & Library Drug Affinity Animal Models Clinical Trials Genetic Targets Isolation Development & Selectivity of Disease States & Therapeutics Combinatorial Structure Activity Cellular Behavioural Genomics Disease Models Studies Chemistry Studies Assay In Silico Mechanism Functional Proteomics Development Screening of Action Imaging Bioinformatics High-throughput Chemical Lead Candidate Ex Vivo Screening Synthesis Refinement Studies Target Lead Medicinal In Vitro In Vivo Selection Discovery Chemistry Studies Studies Text Here Text Here Text Here Text Here Text Here Text Here • Your Text • Your Text • Your Text • Your Text • Your Text • Your Text Goes here Goes here Goes here Goes here Goes here Goes here • Download • Download • Download • Download • Download • Download this this this this this this awesome awesome awesome awesome awesome awesome diagram diagram diagram diagram diagram diagram www.slideteam.net Your logo

5. Drug Discovery Process - Style 5 Cellular & Synthesis & Library Drug Affinity Animal Models Clinical Trials Genetic Targets Isolation Development & Selectivity of Disease States & Therapeutics Combinatorial Structure Activity Cellular Behavioural Genomics Disease Models Studies Chemistry Studies Assay In Silico Mechanism Functional Proteomics Development Screening of Action Imaging Bioinformatics High-throughput Chemical Lead Candidate Ex Vivo Screening Synthesis Refinement Studies Target Lead Medicinal In Vitro In Vivo Selection Discovery Chemistry Studies Studies Text Here Text Here Text Here Text Here Text Here Text Here • Your Text • Your Text • Your Text • Your Text • Your Text • Your Text Goes here Goes here Goes here Goes here Goes here Goes here • Download • Download • Download • Download • Download • Download this this this this this this awesome awesome awesome awesome awesome awesome diagram diagram diagram diagram diagram diagram www.slideteam.net Your logo

6. Drug Discovery Process - Style 5 Cellular & Synthesis & Library Drug Affinity Animal Models Clinical Trials Genetic Targets Isolation Development & Selectivity of Disease States & Therapeutics Combinatorial Structure Activity Cellular Behavioural Genomics Disease Models Studies Chemistry Studies Assay In Silico Mechanism Functional Proteomics Development Screening of Action Imaging Bioinformatics High-throughput Chemical Lead Candidate Ex Vivo Screening Synthesis Refinement Studies Target Lead Medicinal In Vitro In Vivo Selection Discovery Chemistry Studies Studies Text Here Text Here Text Here Text Here Text Here Text Here • Your Text • Your Text • Your Text • Your Text • Your Text • Your Text Goes here Goes here Goes here Goes here Goes here Goes here • Download • Download • Download • Download • Download • Download this this this this this this awesome awesome awesome awesome awesome awesome diagram diagram diagram diagram diagram diagram www.slideteam.net Your logo

7. Drug Discovery Process - Style 5 Cellular & Synthesis & Library Drug Affinity Animal Models Clinical Trials Genetic Targets Isolation Development & Selectivity of Disease States & Therapeutics Combinatorial Structure Activity Cellular Behavioural Genomics Disease Models Studies Chemistry Studies Assay In Silico Mechanism Functional Proteomics Development Screening of Action Imaging Bioinformatics High-throughput Chemical Lead Candidate Ex Vivo Screening Synthesis Refinement Studies Target Lead Medicinal In Vitro In Vivo Selection Discovery Chemistry Studies Studies Text Here Text Here Text Here Text Here Text Here Text Here • Your Text • Your Text • Your Text • Your Text • Your Text • Your Text Goes here Goes here Goes here Goes here Goes here Goes here • Download • Download • Download • Download • Download • Download this this this this this this awesome awesome awesome awesome awesome awesome diagram diagram diagram diagram diagram diagram www.slideteam.net Your logo

8. Drug Discovery Process - Style 5 Cellular & Synthesis & Library Drug Affinity Animal Models Clinical Trials Genetic Targets Isolation Development & Selectivity of Disease States & Therapeutics Combinatorial Structure Activity Cellular Behavioural Genomics Disease Models Studies Chemistry Studies Assay In Silico Mechanism Functional Proteomics Development Screening of Action Imaging Bioinformatics High-throughput Chemical Lead Candidate Ex Vivo Screening Synthesis Refinement Studies Target Lead Medicinal In Vitro In Vivo Selection Discovery Chemistry Studies Studies Text Here Text Here Text Here Text Here Text Here Text Here • Your Text • Your Text • Your Text • Your Text • Your Text • Your Text Goes here Goes here Goes here Goes here Goes here Goes here • Download • Download • Download • Download • Download • Download this this this this this this awesome awesome awesome awesome awesome awesome diagram diagram diagram diagram diagram diagram www.slideteam.net Your logo

9. All images are 100% editable in Powerpoint “Change color, size and orientation of any icon to your liking” www.slideteam.net

10. Ungrouping the object 2 1 3 1. Right click the object. 2. Choose Group and then Ungroup. 3. Click beside the object and drag the arrow over it. www.slideteam.net

11. Edit Color 2 3 1 1. Select the shape to change the color and Right click the object( click any object which you want to change color) 2. Choose Format Shape in the dialog box. 3. Choose “Fill” in the Format Shape box then “Solid” or “Gradient” depending on the appearance of the object. Change colour as shown in the picture. www.slideteam.net

Target selection lead discovery medicinal drug discovery strategy design 5 powerpoint presentation templates.

Recommended

Recommended

More Related Content

What's hot

What's hot (7)

Viewers also liked

Viewers also liked (20)

Similar to Target selection lead discovery medicinal drug discovery strategy design 5 powerpoint presentation templates.

Similar to Target selection lead discovery medicinal drug discovery strategy design 5 powerpoint presentation templates. (14)

More from SlideTeam.net

More from SlideTeam.net (20)

Recently uploaded

Recently uploaded (20)

Target selection lead discovery medicinal drug discovery strategy design 5 powerpoint presentation templates.